10/6/2023 11:01 AM
Apellis Pharmaceuticals Inc (NASDAQ:APLS) stock is enjoying a boost today after an upgrade from J.P. Morgan Securities to "overweight" from "neutral." The firm also lifted its price target to $81 from...
8/23/2023 11:22 AM
The shares of Apellis Pharmaceuticals Inc (NASDAQ:APLS) are soaring, after the biopharmaceutical concern identified the potential cause of an issue with its eye disorder treatment, Syfovre, which tre...